These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 14531810)

  • 1. Role of excess volume in the pathophysiology of hypertension in chronic kidney disease.
    Vasavada N; Agarwal R
    Kidney Int; 2003 Nov; 64(5):1772-9. PubMed ID: 14531810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind randomized crossover trial of two loop diuretics in chronic kidney disease.
    Vasavada N; Saha C; Agarwal R
    Kidney Int; 2003 Aug; 64(2):632-40. PubMed ID: 12846760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
    De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
    Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decongestion strategies and renin-angiotensin-aldosterone system activation in acute heart failure.
    Mentz RJ; Stevens SR; DeVore AD; Lala A; Vader JM; AbouEzzeddine OF; Khazanie P; Redfield MM; Stevenson LW; O'Connor CM; Goldsmith SR; Bart BA; Anstrom KJ; Hernandez AF; Braunwald E; Felker GM
    JACC Heart Fail; 2015 Feb; 3(2):97-107. PubMed ID: 25543972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of furosemide in uncontrolled hypertension in the elderly: role of renin profiling.
    Vlase HL; Panagopoulos G; Michelis MF
    Am J Hypertens; 2003 Mar; 16(3):187-93. PubMed ID: 12620696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of furosemide on left ventricular mass in non-dialysis chronic kidney disease patients: a randomized controlled trial.
    Zamboli P; De Nicola L; Minutolo R; Chiodini P; Crivaro M; Tassinario S; Bellizzi V; Conte G
    Nephrol Dial Transplant; 2011 May; 26(5):1575-83. PubMed ID: 20876366
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Importance of volume factors in dialysis related hypertension.
    Lins RL; Elseviers M; Rogiers P; Van Hoeyweghen RJ; De Raedt H; Zachee P; Daelemans RA
    Clin Nephrol; 1997 Jul; 48(1):29-33. PubMed ID: 9247775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Torasemide in advanced renal failure.
    Kindler J
    Cardiovasc Drugs Ther; 1993 Jan; 7 Suppl 1():75-80. PubMed ID: 8435381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of short-acting and long-acting loop diuretics on heart rate variability in patients with chronic compensated congestive heart failure.
    Tomiyama H; Nakayama T; Watanabe G; Shiojima K; Sakuma Y; Yamamoto A; Imai Y; Yoshida H; Doba N
    Am Heart J; 1999 Mar; 137(3):543-8. PubMed ID: 10047639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in N-terminal pro-brain natriuretic peptide correlate with fluid volume changes assessed by bioimpedance in peritoneal dialysis patients.
    Davenport A
    Am J Nephrol; 2012; 36(4):371-6. PubMed ID: 23051933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Randomized Trial of Distal Diuretics versus Dietary Sodium Restriction for Hypertension in Chronic Kidney Disease.
    Bovée DM; Visser WJ; Middel I; De Mik-van Egmond A; Greupink R; Masereeuw R; Russel FGM; Danser AHJ; Zietse R; Hoorn EJ
    J Am Soc Nephrol; 2020 Mar; 31(3):650-662. PubMed ID: 31996411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comprehensive review of the loop diuretics: should furosemide be first line?
    Wargo KA; Banta WM
    Ann Pharmacother; 2009 Nov; 43(11):1836-47. PubMed ID: 19843838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral administration of furosemide and torsemide in healthy dogs.
    Hori Y; Takusagawa F; Ikadai H; Uechi M; Hoshi F; Higuchi S
    Am J Vet Res; 2007 Oct; 68(10):1058-63. PubMed ID: 17916010
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medium term effects of different dosage of diuretic, sodium, and fluid administration on neurohormonal and clinical outcome in patients with recently compensated heart failure.
    Paterna S; Parrinello G; Cannizzaro S; Fasullo S; Torres D; Sarullo FM; Di Pasquale P
    Am J Cardiol; 2009 Jan; 103(1):93-102. PubMed ID: 19101237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Torsemide versus furosemide after continuous renal replacement therapy due to acute renal failure in cardiac surgery patients.
    Vargas Hein O; Staegemann M; Wagner D; von Heymann C; Martin M; Morgera S; Spies C
    Ren Fail; 2005; 27(4):385-92. PubMed ID: 16060124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Electrolyte and acid-base balance disorders in advanced chronic kidney disease].
    Alcázar Arroyo R
    Nefrologia; 2008; 28 Suppl 3():87-93. PubMed ID: 19018744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease.
    Ohara K; Masuda T; Morinari M; Okada M; Miki A; Nakagawa S; Murakami T; Oka K; Asakura M; Miyazawa Y; Maeshima A; Akimoto T; Saito O; Nagata D
    Diabetol Metab Syndr; 2020; 12():37. PubMed ID: 32377235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single dose comparison of torasemide and furosemide in patients with advanced renal failure.
    Klütsch K; Grosswendt J; Haecker W
    Arzneimittelforschung; 1988 Jan; 38(1A):200-4. PubMed ID: 3285834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of diuretic use in pre-dialysis CKD patients with moderate renal deterioration attending tertiary care referral center.
    Khan YH; Sarriff A; Adnan AS; Khan AH; Mallhi TH
    Clin Exp Nephrol; 2017 Dec; 21(6):1011-1023. PubMed ID: 28271257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain natriuretic peptide enhances renal actions of furosemide and suppresses furosemide-induced aldosterone activation in experimental heart failure.
    Cataliotti A; Boerrigter G; Costello-Boerrigter LC; Schirger JA; Tsuruda T; Heublein DM; Chen HH; Malatino LS; Burnett JC
    Circulation; 2004 Apr; 109(13):1680-5. PubMed ID: 15023890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.